1. Home
  2. PHIO
  3. PHIO News

Latest Phio Pharmaceuticals Corp. (PHIO) News on October 6, 2024

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
PHIO

Newsfile

4 days ago

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference
PHIO

Newsfile

5 days ago

Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference

INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
PHIO

Newsfile

11 days ago

INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
PHIO

Newsfile

19 days ago

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
PHIO

Newsfile

20 days ago

Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA

Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PHIO

Newsfile

a month ago

Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
PHIO

Newsfile

a month ago

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

Phio Pharmaceuticals Corp.'s (NASDAQ:PHIO) Path To Profitability
PHIO

Simply Wall St.

a month ago

Phio Pharmaceuticals Corp.'s (NASDAQ:PHIO) Path To Profitability

Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
PHIO

Newsfile

2 months ago

Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound
PHIO

Newsfile

2 months ago

Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound

Phio Pharmaceuticals Announces New Chief Financial Officer
PHIO

Newsfile

2 months ago

Phio Pharmaceuticals Announces New Chief Financial Officer

Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds
PHIO

Newsfile

3 months ago

Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds

Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762
PHIO

Newsfile

3 months ago

Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762

Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds
PHIO

Newsfile

3 months ago

Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds

PHIO

MT Newswires

3 months ago

Phio Pharmaceuticals Board Approves 1-For-9 Reverse Stock Split

Phio Pharmaceuticals Announces Reverse Stock Split
PHIO

Newsfile

3 months ago

Phio Pharmaceuticals Announces Reverse Stock Split

Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging
PHIO

Newsfile

4 months ago

Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging

Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762
PHIO

Newsfile

4 months ago

Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762

Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
PHIO

Newsfile

4 months ago

Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)

PHIO

MT Newswires

5 months ago

Phio Pharmaceuticals Files $100 Million Mixed Shelf

Phio Pharmaceuticals Secures New Investor
PHIO

GlobeNewswire

5 months ago

Phio Pharmaceuticals Secures New Investor

Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)
PHIO

GlobeNewswire

5 months ago

Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)

PHIO

MT Newswires

5 months ago

Phio Pharmaceuticals Doses 1st Group in Skin Cancer Treatment Study

Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study
PHIO

GlobeNewswire

5 months ago

Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study

Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
PHIO

GlobeNewswire

5 months ago

Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update

Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
PHIO

GlobeNewswire

5 months ago

Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)

Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
PHIO

GlobeNewswire

5 months ago

Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells

Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
PHIO

GlobeNewswire

6 months ago

Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)

Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
PHIO

GlobeNewswire

6 months ago

Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)

National Spotlight Features Phio’s Innovative RNAi Technology Platform
PHIO

GlobeNewswire

6 months ago

National Spotlight Features Phio’s Innovative RNAi Technology Platform

Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
PHIO

GlobeNewswire

6 months ago

Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update

Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
PHIO

GlobeNewswire

7 months ago

Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies

Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
PHIO

GlobeNewswire

7 months ago

Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research

Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
PHIO

GlobeNewswire

7 months ago

Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders

Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
PHIO

GlobeNewswire

8 months ago

Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies

Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib
PHIO

GlobeNewswire

8 months ago

Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib

Gamida Cell Actively Pursuing Strategic Alternatives
PHIO

GlobeNewswire

8 months ago

Gamida Cell Actively Pursuing Strategic Alternatives

Lexaria Releases Annual Letter from the CEO
PHIO

ACCESSWIRE

8 months ago

Lexaria Releases Annual Letter from the CEO

Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
PHIO

PR Newswire

9 months ago

Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients

DecisionPoint (DPSI) Unveils PointCare to Offer Tech Services
PHIO

Zacks

9 months ago

DecisionPoint (DPSI) Unveils PointCare to Offer Tech Services

Sidoti Events, LLC's Virtual January Micro-Cap Conference
PHIO

ACCESSWIRE

9 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference
PHIO

GlobeNewswire

9 months ago

Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference

Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PHIO

PR Newswire

9 months ago

Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Foremost Lithium Receives Multi-Year Work Permit to Commence Drilling on its Jean Lake Lithium/Gold Property
PHIO

GlobeNewswire

9 months ago

Foremost Lithium Receives Multi-Year Work Permit to Commence Drilling on its Jean Lake Lithium/Gold Property

Urban Farming Frontiers: 3 Stocks Growing Greens in the City
PHIO

InvestorPlace

9 months ago

Urban Farming Frontiers: 3 Stocks Growing Greens in the City

Foremost Lithium Announces Receipt of Third $300,000 Grant from The Manitoba Mineral Development Fund (MMDF)
PHIO

GlobeNewswire

9 months ago

Foremost Lithium Announces Receipt of Third $300,000 Grant from The Manitoba Mineral Development Fund (MMDF)

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC
PHIO

GlobeNewswire

9 months ago

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC

BTC Digital Ltd. Announces Purchase of 2,000 Units of T21 Miners
PHIO

PR Newswire

9 months ago

BTC Digital Ltd. Announces Purchase of 2,000 Units of T21 Miners

BTC Digital Ltd. Announces Entry into Share Subscription Agreements in Connection with Private Placement of Ordinary Shares
PHIO

PR Newswire

9 months ago

BTC Digital Ltd. Announces Entry into Share Subscription Agreements in Connection with Private Placement of Ordinary Shares

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure
PHIO

GlobeNewswire

9 months ago

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

Eterna Therapeutics Appoints Sanjeev Luther as President and CEO
PHIO

Exec Edge

10 months ago

Eterna Therapeutics Appoints Sanjeev Luther as President and CEO

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
PHIO

Business Wire

10 months ago

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million
PHIO

PR Newswire

10 months ago

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million

Here's Why We're A Bit Worried About Moleculin Biotech's (NASDAQ:MBRX) Cash Burn Situation
PHIO

Simply Wall St.

10 months ago

Here's Why We're A Bit Worried About Moleculin Biotech's (NASDAQ:MBRX) Cash Burn Situation

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results
PHIO

Business Wire

10 months ago

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results

CHEERS Video Announces Product Upgrade and Rebrands as CHEERS Lifestyle Architect
PHIO

PR Newswire

10 months ago

CHEERS Video Announces Product Upgrade and Rebrands as CHEERS Lifestyle Architect

Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American
PHIO

PR Newswire

10 months ago

Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING
PHIO

PR Newswire

10 months ago

GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
PHIO

GlobeNewswire

10 months ago

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

CHEERS Telepathy Elevates to AI Marketing Tool for Creative Content Across the Value Chain
PHIO

PR Newswire

10 months ago

CHEERS Telepathy Elevates to AI Marketing Tool for Creative Content Across the Value Chain

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
PHIO

PR Newswire

10 months ago

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium

Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
PHIO

GlobeNewswire

10 months ago

Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds

Fathom Realty to raise agent fees in 2024 to boost earnings
PHIO

HousingWire

10 months ago

Fathom Realty to raise agent fees in 2024 to boost earnings

IPA Announces Proposed Public Offering of Common Shares
PHIO

Business Wire

10 months ago

IPA Announces Proposed Public Offering of Common Shares

NeoVolta's Solar Innovation Lights Up the Future: Surpasses 25 Gigawatts in Solar Production
PHIO

GlobeNewswire

10 months ago

NeoVolta's Solar Innovation Lights Up the Future: Surpasses 25 Gigawatts in Solar Production

ZW Data Action Technologies Announces Strategic Partnership with Digital Life to Develop Franchise AI Model
PHIO

GlobeNewswire

10 months ago

ZW Data Action Technologies Announces Strategic Partnership with Digital Life to Develop Franchise AI Model

SatixFy Receives NYSE American Notice of Non-compliance with Continued Listing Standards
PHIO

Business Wire

10 months ago

SatixFy Receives NYSE American Notice of Non-compliance with Continued Listing Standards

ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting
PHIO

GlobeNewswire

10 months ago

ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)
PHIO

Business Wire

10 months ago

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)

Altisource Portfolio Solutions (NASDAQ:ASPS) investors are sitting on a loss of 81% if they invested five years ago
PHIO

Simply Wall St.

10 months ago

Altisource Portfolio Solutions (NASDAQ:ASPS) investors are sitting on a loss of 81% if they invested five years ago

Locafy Reports Fiscal First Quarter 2024 Results
PHIO

GlobeNewswire

10 months ago

Locafy Reports Fiscal First Quarter 2024 Results

HeartCore’s Subsidiary Sigmaways Launches Psyche60s Virtual Reality Experience
PHIO

GlobeNewswire

10 months ago

HeartCore’s Subsidiary Sigmaways Launches Psyche60s Virtual Reality Experience

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
PHIO

GlobeNewswire

a year ago

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference

Market Sentiment Around Loss-Making NeoVolta Inc. (NASDAQ:NEOV)
PHIO

Simply Wall St.

a year ago

Market Sentiment Around Loss-Making NeoVolta Inc. (NASDAQ:NEOV)

Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky
PHIO

Simply Wall St.

a year ago

Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky

PHIO

Thomson Reuters StreetEvents

a year ago

Q3 2023 Eagle Point Income Company Inc Earnings Call

Tims China Announces Third Quarter 2023 Financial Results
PHIO

GlobeNewswire

a year ago

Tims China Announces Third Quarter 2023 Financial Results

PHIO

Thomson Reuters StreetEvents

a year ago

Q3 2023 Eagle Point Credit Company Inc Earnings Call

ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights
PHIO

GlobeNewswire

a year ago

ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights

Eagle Point Income Company Inc. Announces Third Quarter 2023 Financial Results
PHIO

Business Wire

a year ago

Eagle Point Income Company Inc. Announces Third Quarter 2023 Financial Results

Globus Maritime Sets Date for the Release of Third Quarter and Nine Months 2023 Results
PHIO

GlobeNewswire

a year ago

Globus Maritime Sets Date for the Release of Third Quarter and Nine Months 2023 Results

Siebert Reports Third Quarter 2023 Financial Results
PHIO

Business Wire

a year ago

Siebert Reports Third Quarter 2023 Financial Results

Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile
PHIO

GlobeNewswire

a year ago

Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile

FGI Industries Ltd. (NASDAQ:FGI) Q3 2023 Earnings Call Transcript
PHIO

Insider Monkey

a year ago

FGI Industries Ltd. (NASDAQ:FGI) Q3 2023 Earnings Call Transcript

Nephros, Inc. (NASDAQ:NEPH) Q3 2023 Earnings Call Transcript
PHIO

Insider Monkey

a year ago

Nephros, Inc. (NASDAQ:NEPH) Q3 2023 Earnings Call Transcript

PHIO

Thomson Reuters StreetEvents

a year ago

Q3 2023 Energous Corp Earnings Call

PHIO

Associated Press Finance

a year ago

Energous: Q3 Earnings Snapshot

Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
PHIO

GlobeNewswire

a year ago

Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Energous Corporation Reports 2023 Third-Quarter Results
PHIO

Business Wire

a year ago

Energous Corporation Reports 2023 Third-Quarter Results

Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
PHIO

ACCESSWIRE

a year ago

Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform

Phio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin Carcinomas
PHIO

GlobeNewswire

a year ago

Phio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin Carcinomas

BK Technologies Announces Third Quarter 2023 Results
PHIO

ACCESSWIRE

a year ago

BK Technologies Announces Third Quarter 2023 Results

Analysts Just Made A Major Revision To Their Synchronoss Technologies, Inc. (NASDAQ:SNCR) Revenue Forecasts
PHIO

Simply Wall St.

a year ago

Analysts Just Made A Major Revision To Their Synchronoss Technologies, Inc. (NASDAQ:SNCR) Revenue Forecasts

AGBA Group Entered Into Term Sheets for US$6.2 Million Private Placement Offering
PHIO

GlobeNewswire

a year ago

AGBA Group Entered Into Term Sheets for US$6.2 Million Private Placement Offering

Synchronoss Technologies, Inc. (NASDAQ:SNCR) Q3 2023 Earnings Call Transcript
PHIO

Insider Monkey

a year ago

Synchronoss Technologies, Inc. (NASDAQ:SNCR) Q3 2023 Earnings Call Transcript

Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now
PHIO

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now

Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
PHIO

GlobeNewswire

a year ago

Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023

Share on Social Networks: